These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31660317)

  • 21. Is the clinical presentation of chronic heart failure different in elderly versus younger patients and those with preserved versus reduced ejection fraction?
    Steinmann E; Brunner-La Rocca HP; Maeder MT; Kaufmann BA; Pfisterer M; Rickenbacher P
    Eur J Intern Med; 2018 Nov; 57():61-69. PubMed ID: 29908708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.
    Farmakis D; Simitsis P; Bistola V; Triposkiadis F; Ikonomidis I; Katsanos S; Bakosis G; Hatziagelaki E; Lekakis J; Mebazaa A; Parissis J
    Clin Res Cardiol; 2017 May; 106(5):359-368. PubMed ID: 27999929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CardioMEMS
    Mangi MA; Nesheiwat Z; Kahloon R; Moukarbel GV
    Expert Rev Med Devices; 2020 Jul; 17(7):637-648. PubMed ID: 32500762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.
    Kontogeorgos S; Thunström E; Johansson MC; Fu M
    Int J Cardiol; 2017 Apr; 232():86-92. PubMed ID: 28100428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary artery catheterization use and mortality in hospitalizations with HFrEF and HFpEF: A nationally representative trend analysis from 2005 to 2014.
    Doshi R; Patel H; Shah P
    Int J Cardiol; 2018 Oct; 269():289-291. PubMed ID: 30025656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Case report on ambulatory pulmonary pressure monitoring: an attempt to reduce readmissions for heart failure with preserved ejection fraction.
    Angullo-Gómez M; Robles-Mezcua A; Becerra-Muñoz VM; García-Pinilla JM
    Eur Heart J Case Rep; 2022 Oct; 6(10):ytac401. PubMed ID: 36285229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes.
    Nadruz W; West E; Santos M; Skali H; Groarke JD; Forman DE; Shah AM
    Circ Heart Fail; 2016 Apr; 9(4):e002826. PubMed ID: 27009553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcatheter Implantable Devices to Monitoring of Elevated Left Atrial Pressures in Patients with Chronic Heart Failure.
    De Rosa R; Piscione F; Schranz D; Citro R; Iesu S; Galasso G
    Transl Med UniSa; 2017 Jul; 17():19-21. PubMed ID: 30050876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An update on the CardioMEMS pulmonary artery pressure sensor.
    Ayyadurai P; Alkhawam H; Saad M; Al-Sadawi MA; Shah NN; Kosmas CE; Vittorio TJ
    Ther Adv Cardiovasc Dis; 2019; 13():1753944719826826. PubMed ID: 30803405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-Effectiveness of Remote Cardiac Monitoring With the CardioMEMS Heart Failure System: A Systematic Review.
    Azari S; Mousavi SH; Markazi Moghaddam N; Rezapour A; Zargar Balaye Jame S; Kolivand P; Sarabi Asiabar A
    Med J Islam Repub Iran; 2023; 37():16. PubMed ID: 37123330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
    Sartipy U; Dahlström U; Fu M; Lund LH
    JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomised comparison of the effect of haemodynamic monitoring with CardioMEMS in addition to standard care on quality of life and hospitalisations in patients with chronic heart failure : Design and rationale of the MONITOR HF multicentre randomised clinical trial.
    Brugts JJ; Veenis JF; Radhoe SP; Linssen GCM; van Gent M; Borleffs CJW; van Ramshorst J; van Pol P; Tukkie R; Spee RF; Emans ME; Kok W; van Halm V; Handoko L; Beeres SLMA; Post MC; Boersma E; Lenzen MJ; Manintveld OC; Koffijberg H; van Baal P; Versteegh M; Smilde TD; van Heerebeek L; Rienstra M; Mosterd A; Delnoy PPH; Asselbergs FW; Brunner-La Rocca HP; de Boer RA
    Neth Heart J; 2020 Jan; 28(1):16-26. PubMed ID: 31776915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Large pulmonary artery pseudoaneurysm after CardioMEMS implantation: a case report.
    Garg T; Raikhelkar J; Gilkeson R; Tavri S
    Eur Heart J Case Rep; 2022 Apr; 6(4):ytac113. PubMed ID: 35481254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding adherence to the CardioMEMS pulmonary artery pressure monitoring system for heart failure: A qualitative study.
    Haynes SC; Pallin R; Tong K; Henderson S; Romano PS
    Heart Lung; 2020; 49(3):251-258. PubMed ID: 32087985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ambulatory pulmonary artery pressure monitoring in advanced heart failure patients.
    Yandrapalli S; Raza A; Tariq S; Aronow WS
    World J Cardiol; 2017 Jan; 9(1):21-26. PubMed ID: 28163833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interventions Linked to Decreased Heart Failure Hospitalizations During Ambulatory Pulmonary Artery Pressure Monitoring.
    Costanzo MR; Stevenson LW; Adamson PB; Desai AS; Heywood JT; Bourge RC; Bauman J; Abraham WT
    JACC Heart Fail; 2016 May; 4(5):333-44. PubMed ID: 26874388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heart failure with preserved ejection fraction: current management and future strategies : Expert opinion on the behalf of the Nucleus of the "Heart Failure Working Group" of the German Society of Cardiology (DKG).
    Tschöpe C; Birner C; Böhm M; Bruder O; Frantz S; Luchner A; Maier L; Störk S; Kherad B; Laufs U
    Clin Res Cardiol; 2018 Jan; 107(1):1-19. PubMed ID: 29018938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The CardioMEMS system in the clinical management of end-stage heart failure patients: three case reports.
    Tschöpe C; Alogna A; Spillmann F; Faragli A; Schmidt G; Blaschke F; Kühl U; Hertel E; Willner M; Morris D; Post H; Noutsias M; Pieske B; Krackhardt F
    BMC Cardiovasc Disord; 2018 Jul; 18(1):155. PubMed ID: 30064356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age-dependent differences in clinical phenotype and prognosis in heart failure with mid-range ejection compared with heart failure with reduced or preserved ejection fraction.
    Chen X; Savarese G; Dahlström U; Lund LH; Fu M
    Clin Res Cardiol; 2019 Dec; 108(12):1394-1405. PubMed ID: 30980205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry.
    Senni M; Gavazzi A; Oliva F; Mortara A; Urso R; Pozzoli M; Metra M; Lucci D; Gonzini L; Cirrincione V; Montagna L; Di Lenarda A; Maggioni AP; Tavazzi L;
    Int J Cardiol; 2014 May; 173(2):163-9. PubMed ID: 24630337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.